According to projections, the influenza treatment market will achieve a size of USD 1.2 billion by 2026

Influenza, commonly known as the flu, is a viral infection that affects the respiratory system. The symptoms of the flu include fever, cough, sore throat, body aches, and fatigue. While most people recover from the flu without any specific treatment, antiviral medications may be prescribed in some cases. These medications can help to reduce the severity and duration of the illness, especially if they are taken within 48 hours of symptom onset.

Other treatment options for the flu include getting plenty of rest, drinking fluids to stay hydrated, and taking over-the-counter medications to relieve symptoms. It is important to practice good hygiene to prevent the spread of the flu virus, including washing your hands regularly and avoiding close contact with others who are sick.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 - https://www.alliedmarketresearch.com/request-sample/6471

•CAGR: 5.1%
• Current Market Size: USD 575.3 Million
• Forecast Growing Region: APAC
• Largest Market: North America
• Projection Time: 2021- 2031
• Base Year: 2021

The global influenza treatment market size was valued at $862 million in 2018, and is expected to reach $1.2 billion by 2026, registering a CAGR of 4.5% from 2019 to 2026.

To provide a comprehensive analysis of the influenza treatment market size, the market is evaluated based on product type, distribution channel, and region. The product type segment is divided into Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, and others. The distribution channel segment is categorized into retail pharmacy, hospital pharmacy, and others.

Geographically, the market is studied across North America, which includes the U.S., Canada, and Mexico, Europe, which comprises Germany, France, the UK, Italy, and rest of Europe, Asia-Pacific, which includes China, Japan, India, and rest of Asia-Pacific, and LAMEA, which includes Brazil, South Africa, and rest of LAMEA.

This detailed assessment enables a comprehensive understanding of the influenza treatment market and its various segments.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (194 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/influenza-treatment-market/purchase-options

In 2018, North America dominated the influenza treatment market, primarily due to the easy availability of treatment options and a high incidence rate of influenza infections. This trend is expected to continue in the coming years.

However, the Asia-Pacific region is projected to witness the fastest growth during the forecast period, driven by rising awareness regarding the use of influenza drugs for treatment and the constantly evolving life science industry. Developing economies such as India, China, and Malaysia are expected to contribute significantly to this growth as awareness related to influenza treatment continues to increase due to ongoing developments in the region.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 - https://www.alliedmarketresearch.com/purchase-enquiry/6471

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐨𝐟 𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐲
• Oseltamivir phosphate occupied more than two-fifth share of the global influenza treatment market in 2018.

• The others segment in distribution channel pharmacy segment is anticipated to grow with the highest CAGR throughout the forecast period.

• The others segment in product type accounted for more than two-fifth share of the market in 2018.

• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞 𝐭𝐨 𝐠𝐞𝐭 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 - https://www.alliedmarketresearch.com/influenza-treatment-market-A0610

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬: 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 - 𝐆𝐞𝐭 10% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭
𝐂𝐚𝐧𝐜𝐞𝐫 𝐒𝐮𝐩𝐩𝐨𝐫𝐭𝐢𝐯𝐞 𝐂𝐚𝐫𝐞 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/cancer-supportive-care-drugs-market-A07133

𝐕𝐞𝐭𝐞𝐫𝐢𝐧𝐚𝐫𝐲 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/veterinary-oncology-market-A07139

𝐒𝐭𝐞𝐫𝐢𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/sterilization-services-market-A07513

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.